Published on 01 January 2022

Asian Multicentre, Double Blind, Randomised, Placebo Controlled Pilot Study, to Assess the Impact of Dysport® Intramuscular Injections When Administered Within the First 12 Weeks After Stroke on the Time to Spasticity Progression in Adult Subjects With Upper Limb (UL) Spasticity.

Ipsen

Description

The purpose of this study is to investigate if early administration (i.e. within 12 weeks after stroke) of Dysport® 500 U injections may delay the appearance or the progression of upper limb symptomatic spasticity.

Citations (0)

No citations found

It looks like this dataset has no citations.

Mentions (0)

No mentions found

It looks like this dataset has not been mentioned in any sources.

Metrics

Dataset Index

0.8

FAIR Score

31%

Citations

Mentions

Metrics Over Time

Publication Details

DOI

10.25934/pr00008367

Publisher

Vivli

Assigned Domain

Subfield

Emergency Medicine

Field

Medicine

Domain

Health Sciences

Confidence Score

53%

Source

Scholar Data Model

Keywords

Conditions: StrokeConditions: Upper Limb SpasticityInterventions: Botulinum toxin type AInterventions: Placebo

Normalization Factors

13.46

CTw

1.00

MTw

1.00